ストックスクリーナーアプリを入手
69.46
1.85%
-1.31
前日終値:
$70.77
開ける：
$70.84
24時間の取引高:
660.90K
Relative Volume:
0.61
時価総額：
$9.11B
収益：
-
当期純損益:
$-507.65M
株価収益率:
-15.10
EPS:
-4.6
ネットキャッシュフロー:
$-616.24M
1週間 パフォーマンス:
-6.96%
1か月 パフォーマンス:
-6.41%
6か月 パフォーマンス:
-38.61%
1年 パフォーマンス:
+1.68%
1日の値動き範囲:
$68.38
$71.22
1週間の範囲:
$68.36
$75.33
52週間の値動き範囲:
$58.10
$121.06
Vaxcyte Inc Stock (PCVX) Company Profile
名前
Vaxcyte Inc
セクター
電話
650-837-0111
住所
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
PCVX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PCVX
Vaxcyte Inc
|
69.46 | 9.11B | 0 | -507.65M | -616.24M | -4.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-20 | 開始されました | Goldman | Buy |
| 2023-12-07 | 開始されました | Mizuho | Buy |
| 2023-04-18 | 開始されました | TD Cowen | Outperform |
| 2023-01-03 | 繰り返されました | Needham | Buy |
| 2022-12-15 | 開始されました | Guggenheim | Buy |
| 2022-11-17 | 開始されました | BTIG Research | Buy |
| 2021-12-29 | 再開されました | Jefferies | Buy |
| 2021-06-24 | 再開されました | Jefferies | Buy |
| 2020-07-07 | 開始されました | BofA Securities | Buy |
| 2020-07-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-07-07 | 開始されました | Needham | Buy |
すべてを表示
Vaxcyte Inc (PCVX) 最新ニュース
Is Vaxcyte, Inc. (PCVX) the Best Up and Coming Stock to Buy According to Wall Street Analysts? - MSN
Vaxcyte (PCVX) Struggled Amid Political Uncertainty - Insider Monkey
Guggenheim Reaffirms Buy Rating for Vaxcyte (NASDAQ:PCVX) - Defense World
Comparing Vaxcyte (NASDAQ:PCVX) and Aptose Biosciences (NASDAQ:APTO) - Defense World
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Smartleaf Asset Management LLC - Defense World
US Bancorp DE Has $408,000 Stake in Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World
Learn to Evaluate (PCVX) using the Charts - Stock Traders Daily
Vaxcyte’s SVP Mikhail Eydelman sells shares worth $353,699 By Investing.com - Investing.com Australia
Insider Sell: Vaxcyte Inc's COO Jim Wassil Sells 3,000 Shares - GuruFocus.com
Mutual of America Capital Management LLC Lowers Stake in Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World
Bank of New York Mellon Corp Boosts Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World
Vaxcyte’s SVP Mikhail Eydelman sells shares worth $353,699 - Investing.com
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by Truist Financial Corp - Defense World
Vaxcyte COO Jim Wassil sells $586,165 in stock By Investing.com - Investing.com Australia
Vaxcyte COO Jim Wassil sells $586,165 in stock - Investing.com India
Vaxcyte, Inc. (PCVX): Among the Cash-Rich Mid Cap Stocks to Buy Now - Insider Monkey
10 Cash-Rich Mid Cap Stocks To Buy Now - Insider Monkey
Vaxcyte phase II PCV valve to open shortly, Pfizer sizers alert - BioWorld Online
Mizuho maintains Vaxcyte stock Outperform rating, $163 target - Investing.com India
(PCVX) Trading Report - Stock Traders Daily
Research Analysts Offer Predictions for Vaxcyte Q1 Earnings - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Handelsbanken Fonder AB - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by New York State Common Retirement Fund - Defense World
Q1 Earnings Estimate for Vaxcyte Issued By Leerink Partnrs - Defense World
PCVXVaxcyte, Inc. Latest Stock News & Market Updates - StockTitan
Guggenheim Reiterates "Buy" Rating for Vaxcyte (NASDAQ:PCVX) - MarketBeat
Vaxcyte (NASDAQ:PCVX) Releases Earnings Results, Beats Expectations By $0.14 EPS - MarketBeat
Vaxcyte's (PCVX) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
Biotech Alert: Searches spiking for these stocks today - TipRanks
Vaxcyte’s Promising Prospects and Strategic Engagements Justify Buy Rating - TipRanks
Vaxcyte’s Earnings Call Highlights Strong Position and Future Growth - TipRanks
Vaxcyte cites manufacturing investments at Lonza facility in Visp as key 2024 expenditure - BioProcess Insider
Decoding Vaxcyte Inc (PCVX): A Strategic SWOT Insight - GuruFocus.com
Why Vaxcyte, Inc. (PCVX) Is One of the Best Vaccine Stocks to Buy According to Hedge Funds - Insider Monkey
Buy Rating for Vaxcyte Driven by Anticipated Positive Phase 2 Data and Undervalued Stock Potential - TipRanks
Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2024 Earnings Call Transcript - Insider Monkey
Vaxcyte Inc (PCVX) Q4 2024 Earnings Call Highlights: Strong Fina - GuruFocus.com
Vaxcyte Advances Vaccine Pipeline with Strong Financial Backing - TipRanks
Vaxcyte Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Vaxcyte Q4 2024 sees stock dip after earnings - Investing.com
10 Best Vaccine Stocks to Buy According to Hedge Funds - Insider Monkey
Vaxcyte 2024 Loss Narrows -February 25, 2025 at 05:22 pm EST - Marketscreener.com
Vaxcyte, Inc. SEC 10-K Report - TradingView
Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times
Vaxcyte, Inc. (PCVX): Among the Stocks That Will Go to The Moon According to Analysts - Insider Monkey
What's Driving the Market Sentiment Around Vaxcyte? - Benzinga
Vaxcyte, Inc. (NASDAQ:PCVX) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
BTIG maintains Vaxcyte stock Buy rating, $160 target By Investing.com - Investing.com Canada
Vaxcyte’s Promising Vaccine Developments and Strong Buy Rating Backed by Robust Clinical Trials and DCF Valuation - TipRanks
15 Stocks That Will Go to The Moon According to Analysts - Insider Monkey
Vaxcyte Inc (PCVX) 財務データ
収益
当期純利益
現金流量
EPS
Vaxcyte Inc (PCVX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC |
Mar 05 '25 |
Sale |
70.74 |
5,000 |
353,699 |
41,620 |
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):